You have searched for "Sinovac"
Showing 1-10 of 623
The wide discrepancy between the clinical trial results of the Sinovac vaccine is explained by the populations they were tested on.
Sinovac releases vaccine data in Brazil: 100% effective in preventing severe cases, could reduce hospitalisations by 80%
BEIJING (Global Times): Sinovac's Covid-19 vaccine is 100 per cent effective in preventing severe and moderate infections, 77.96 per cent effective in preventing mild cases, and has an overall efficacy of 50.4 per cent in Brazil's final-stage trials.
SHANGHAI (Reuters): China’s Sinovac Biotech has secured US$515 million in funding from a local firm to double production capacity of its coronavirus vaccine, the companies said on Monday (Dec 7), as it expects efficacy data of its experimental shot this month.
KUALA LUMPUR: Phamaniaga Bhd has the capacity to manufacture two million doses of Covid-19 vaccine developed by China’s Sinovac Life Sciences Co Ltd per month beginning March this year.
INDONESIA, Aug 11, Reuters: China's Sinovac Biotech Ltd launched on Tuesday a late-stage human trial involving as many as 1,620 patients in Indonesia for a Cocid-19 vaccine candidate that it is developing with Indonesian state-owned peer Bio Farma.
Sinovac has also signed supply deals for its vaccine, called CoronaVac, with countries including Indonesia, Brazil, Chile and Singapore, and is negotiating with the Philippines and Malaysia.
BANGKOK (Reuters): Thailand on Wednesday (Jan 12) said it was still on track to receive and administer a coronavirus vaccine by China's Sinovac Biotech starting next month, despite data from a Brazil trial that showed 50.4% efficiency, health officials said.
Move will allow state-owned PT Bio Farma to produce doses locally
JAKARTA (The Jakarta Post Jakarta/ANN): PT Bio Farma has announced that the state-owned pharmaceutical company plans to submit its interim results from the third and final trial phase of the Sinovac vaccine to the Indonesian Food and Drug Monitoring Agency (BPOM) in January 2021.
JAKARTA (Reuters): Indonesia's state-owned pharmaceutical company Bio Farma said on Tuesday (Dec 8) that interim data on trials it was conducting on vaccines produced by the Chinese company Sinovac showed up to 97 per cent efficacy.